Status:
NOT_YET_RECRUITING
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
Lead Sponsor:
Nova Scotia Health Authority
Collaborating Sponsors:
Dalhousie University
Conditions:
Psychosis
Cannabis Use
Eligibility:
All Genders
18-25 years
Phase:
PHASE4
Brief Summary
Canada reports some of the highest rates of cannabis use in our youth and young adult populations, among all the developed countries. Recent Health Canada surveys report that 27% of 16-19-year-olds an...
Detailed Description
Researchers will compare three groups of young adults with EPP: those using cannabis on a regular basis i) high potency (\>15% THC) and ii) low potency (\<15% THC) cannabis products and iii) patients ...
Eligibility Criteria
Inclusion
- This study will enroll individuals 18-25 years of age from the Nova Scotia Early Psychosis Program
Exclusion
- Current stimulant use disorder
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT07001878
Start Date
July 1 2025
End Date
December 1 2026
Last Update
June 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.